Introduction and aim. In a randomised trial investigating the effects of regular
. They capture patients" experiences of symptoms and impact of disease on functioning, and can support physicians in clinical practice to monitor patient problems and facilitate patient-centred care [3] [4] [5] . Systematic reviews evaluating the impact of PROs on clinical practice demonstrated a positive effect on patient-physician communication, but less consistent improvement in patient health outcomes or satisfaction [6] [7] [8] [9] [10] .
We conducted a randomised controlled trial (RCT) of regular touch-screen computer collection and feedback of HRQOL data to oncologists, confirming a positive effect on physician-patient communication (measured objectively from audio-recorded encounters) and patient well-being 11 . Secondary aims were to measure the impact of the intervention on patient satisfaction and perceptions of continuity and co-ordination of care. Secondary outcomes were expected to provide insight into possible mechanisms underlying the observed changes in patient well-being.
Measures of patient satisfaction in oncology are subject to ceiling effects, as patients do not rate their medical team negatively 12 . We found high general patient satisfaction in the pre-trial pilot and decided to investigate specific aspects of care 13 . Assessment of continuity and co-ordination of care was chosen, as the research was conducted in a tertiary cancer centre with care delivered by teams of physicians (5-8 doctors), and patients were often seen by different physicians.
Continuity of medical care was defined as "the extent to which health services are received as a coordinated and uninterrupted succession of events consistent with the patient"s medical needs" 14 . Continuity of clinical data and information were key components of care coordination 15 . HRQOL measurement can be viewed as a tool that ensures continuous flow of subjective symptoms/functioning information from the patient to the medical team 16 .
This article reports secondary trial outcomes (continuity of care and patient satisfaction) and patients" and doctors" evaluation of the intervention. We hypothesize that the use of patient-reported HRQOL data will improve "coordination" of patient information between doctors and improve "communication" about non-medical problems. These effects may result in less strong "patient preferences" to see usual doctor, as all doctors have similar patient-reported information. We expected patients to report high general satisfaction with care.
METHODS
Trial methodology has been described 11 . Brief key information is provided.
Participants
Patients attending the Medical Oncology Clinic at St James Hospital, Leeds, UK were eligible if they were commencing treatment, expected to attend at least 3-times, fluent in English and not exhibiting psychopathology. All medical oncologists and oncologists-in-training were invited. The study was approved by the institutional ethical committee. Patients and clinicians provided written informed consent. Secondary patient outcomes were measured using paper questionnaires (given to patients to complete at home and return by post) at four time-points: baseline, after 3 visits, 4 and 6 months. Patients' and physicians' evaluation of the intervention. Descriptive information was collected using end-of-study questionnaires for patients and doctors. Topics included: 1) patients" experience with the touch-screen questionnaires; 2) content/relevance of the questionnaires; 3) usefulness of the intervention (willingness to use in routine care) (Appendix 2). End-of-study questionnaires were sent to patients in the intervention and attention-control arms and to doctors working in the centre at the trial closure.
Experimental intervention

Other measures
K-index is as an objective measure of continuity of care, defined as: 
Satisfaction with care, patients' and physicians' evaluation questionnaires
were analysed descriptively.
All analyses were on an intention to treat. Significance level was set at 5% for pre-planned analyses. The analyses were performed with SPSS Windows 
RESULTS
The trial recruited between January 2000 and July 2001. All 28 medical oncologists working in the unit participated: 17 were male (reflecting the malefemale balance in the medical profession in UK); median age 33.5, range 26-51 years; 22 oncologists-in-training and 6 consultants.
Patients" progress through the study is presented in Figure 1 . From 419 eligible patients, 286 patients (68%) consented. The 6 month attrition rate was 35% in the intervention arm, 46% in the attention-control and 33% in the control arm, predominantly due to death (58% of drop-out cases), 87% of patients remaining on study completed the MCQ measure each time.
End of study questionnaires were returned by 91% of patients (119/131 patients in intervention/attention-control arms finishing the study); 22 oncologists, working at the centre at trial closure, completed the questionnaire. Table 1 represents patient characteristics of the sample analysed for secondary outcomes, which were not different from those analysed for primary outcomes 13 .
Continuity and coordination of care.
The results of the mixed-effects models for MCQ subscales change scores are presented in Table 2 and Figure 2 .
Patients in the intervention group rated their "Communication" with doctors significantly better than the control group (p=.03), but not different from the attention-control group (p =.16). Investigating the MCQ scores in relation to the timing of dropout indicated that this is likely to be a conservative estimate.
Patients in the intervention group dropped out when their scores were favourable, whereas patients in the attention-control/control groups dropped out when their scores were poor. The mixed-effects model assuming data is missing-at-random would underestimate the difference between the groups. The control group showed a decline in scores to month 4 followed by improvement by month 6 (Figure 2A ). This improvement can be partially explained by attrition of patients with poor scores. Patient scores were associated with baseline MCQ "Communication" score (p<.0001).
No significant arm effect was found for "Coordination" and "Preferences" subscales, where the change scores were dependent on baseline scores and KIndex.
Satisfaction with care. Between 79% and 89% of patients regardless of study arm rated their quality of care as "very good"/"excellent" (Figure 3 ). Between 89%
and 95% of patients felt the doctors met their expectations (details not shown).
Patients' and physicians' evaluation of the intervention.
Patients did not feel participation in the study made their clinic visits more difficult (98%, n=119). In the intervention arm (n=85) 86% patients perceived the questionnaires were useful to tell the doctors how they were feeling, compared to 29% of patients in the attention-control group (no feedback, n=34). 92% of patients wanted to use the touch-screen intervention in routine care, 76% wanted the scores included in medical records. More patients in the intervention group than the attention-control felt the doctors considered their daily activities (65% vs 53%), emotions (87% vs 71%) and quality of life (90% vs 74%) when treating them. . Our findings suggest a mechanism through which improved doctor-patient communication may lead to better patient well-being. The HRQOL data helped to focus the consultation on topics important to the patient and facilitated discussion of non-medical issues.
This impact was sufficiently large to be noticed by patients and might be expected to contribute to better emotional well-being, as observed in the trial 11 .
Patients expressed strong preferences to see their regular doctor, which was not influenced by the intervention. Similarly, the strongest predictor of "Coordination" Significant attrition can be expected in advanced cancer, but the unbalanced attrition (46% in attention-control arm vs 33-35% in control and intervention arms) may influence results. We investigated possible effects of data not missing-atrandom and found a trend towards underestimating arm differences, but not influencing the direction of results. Bias cannot be completely excluded, as the sample size does not allow more complex modelling for missing data.
In conclusion, this pre-planned analysis of secondary outcomes supports findings 
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